Research Paper Volume 14, Issue 5 pp 2320—2334

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma


Figure 9. (A) The expression of cleaved PARP and PLKs in ON1231320 treated cells was detected using western blotting. (B) Quantitative results of immunoblots. (C) ON1231320 inhibits tumor growth in vivo. (D) Quantitative results of tumor volumes. *P < 0.05 and **P < 0.001 vs. the control groups.